Cascadian Therapeutics, Inc. CASC
No live quote for CASC yet.
Revenue & Expenses
Latest period ending Dec 31, 2017 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2017 Dec 31, 2017 | FY 2016 Dec 31, 2016 | FY 2015 Dec 31, 2015 | FY 2014 Dec 31, 2014 | FY 2013 Dec 31, 2013 |
|---|---|---|---|---|---|
| 58.09M | 64.83M | 32.79M | 50.84M | 41.22M | |
| 43.98M | 27.47M | 23.47M | 41.88M | 33.22M | |
| 14.11M | 17.63M | 9.32M | 8.95M | 8.00M | |
| -58.09M | -64.83M | -32.79M | -50.84M | -41.22M | |
| -56.93M | -57.70M | -32.58M | -49.96M | -38.76M | |
| -57.92M | -60.29M | -32.58M | -49.96M | -38.76M | |
| -57.92M | -60.29M | -32.58M | -49.96M | -38.76M | |
| -56.93M | -57.70M | -32.58M | -49.96M | -38.76M | |
| -1.21 | -3.13 | -2.02 | -3.86 | -3.72 | |
| -1.21 | -3.13 | -2.02 | -3.86 | -3.72 | |
| -1.21 | -3.13 | -2.02 | -3.86 | -3.72 | |
| -56.93M | -64.61M | -32.58M | -49.96M | -38.76M | |
| -56.93M | -64.61M | -32.58M | -49.96M | -38.76M | |
| 982.00K | 2.59M | 0 | 0 | 0 | |
| 47.97M | 19.26M | 16.10M | 12.94M | 10.40M | |
| 47.97M | 19.26M | 16.10M | 12.94M | 10.40M |